Study Confirms Analytical Precision Of MammaTyper® In Molecular Breast Cancer Typing
Mainz, Germany, July 12, 2016 / B3C newswire / -- BioNTech Diagnostics GmbH announces the publication of new study data which confirms the high analytical performance of the in vitro diagnostic test kit MammaTyper® (CE labeled IVD) in breast cancer …